Latham & Watkins Represents The Beauty Health Company In Convertible Debt Refinancing

Latham & Watkins represents The Beauty Health Company in convertible debt refinancing

Latham & Watkins represents The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial™, on its entry into privately negotiated exchange agreements with certain holders of its outstanding 1.25% convertible senior notes due 2026. Under the terms of the Exchange Agreements, the company will exchange approximately US$413.2 million of aggregate principal amount of the existing notes for US$250 million of new 7.95% convertible senior secured notes due 2028, along with approximately US$143.4 million in cash, including accrued and unpaid interest. The company expects to close the Exchange on or around May 27, 2025.

The Latham & Watkins LLP team was led by Capital Markets partners Brent Epstein, Greg Rodgers, and Andrew Blumenthal, with associates Robyn Sablove, Andrew Bentz, and Jessmine Lee. The Private Equity Finance team was led by partner Seniz Yakut, with associates Elizabeth Bell and Michael Hengerer. Advice was also provided on liability management matters by partner John Sobolewski, on tax matters by partner Bora Bozkurt, and on intellectual property matters by counsel David Kuiper.

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.